Transcription of S9 Step 5 Nonclinical evaluation for anticancer ...
{{id}} {{{paragraph}}}
Example: bachelor of science
S9 Step 5 Nonclinical evaluation for anticancer ...
May 2010 EMA/CHMP/ICH/646107/2008 ICH guideline S9 on Nonclinical evaluation for anticancer pharmaceuticals step 5 Transmission to CHMP December 2008 Adoption by CHMP for release for consultation December 2008 End of consultation (deadline for comments) March 2009 Final adoption by CHMP November 2009 Date for coming into effect May 2010 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom An agency of the European Union Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail Website European Medicines Agency, 2013. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Introduction .. 3 Objectives of the guideline.
This guideline aims to facilitate and accelerate the development of anticancer pharmaceuticals and to protect patients from unnecessary adverse effects, while avoiding unnecessary use of animals, in
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: